Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: An 18F-dopa PET study

Journal of Neural Transmission

Volumn 114, Issue 3, 2007, Pages 337-340

  Tai, Y F ^a   Ahsan, R L ^a   De Yebenes J G ^b   Pavese, N ^a   Brooks, D J ^a   Piccini, P ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROXYPHENYLALANINE FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE PREDISPOSITION; DOPAMINERGIC SYSTEM; DRUG UPTAKE; FAMILIAL DISEASE; FEMALE; HUMAN; MALE; MEDICAL DOCUMENTATION; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN;

AGED; AMYGDALA; CEREBRAL CORTEX; CORPUS STRIATUM; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DIHYDROXYPHENYLALANINE; DISEASE PROGRESSION; DOPAMINE; DOWN-REGULATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIMBIC SYSTEM; MALE; PEDIGREE; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 33847281898     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0536-0     Document Type: Article

References (12)

1. Brooks DJ (1994) PET studies in progressive supranuclear palsy. J Neural Transm [Suppl 42]: 119-134
2. J Brown P Lantos M Stratton P Roques M Rossor 1993 Familial progressive supranuclear palsy J Neurol Neurosurg Psychiatry 56 473 476
3. G Chinaglia FJ Alvarez A Probst JM Palacios 1992 Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol Neuroscience 49 317 327
4. Y Higuchi T Iwaki J Tateishi 1995 Neurodegeneration in the limbic and paralimbic system in progressive supranuclear palsy Neuropathol Appl Neurobiol 21 246 254
5. NL Khan DJ Brooks N Pavese MG Sweeney NW Wood AJ Lees P Piccini 2002 Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study Brain 125 2248 2256
6. I Litvan Y Agid D Calne G Campbell B Dubois RC Duvoisin CG Goetz LI Golbe J Grafman JH Growdon M Hallett J Jankovic NP Quinn E Tolosa DS Zee 1996 Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop Neurology 47 1 9
7. CS Patlak RG Blasberg 1985 Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations J Cereb Blood Flow Metab 5 584 590
8. P Piccini J de Yebenez AJ Lees R Ceravolo N Turjanski P Pramstaller DJ Brooks 2001 Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography Arch Neurol 58 1846 1851
9. W Pirker S Djamshidian S Asenbaum W Gerschlager G Tribl M Hoffmann T Brucke 2002 Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study Mov Disord 17 45 53
10. A Rojo RS Pernaute A Fontan PG Ruiz J Honnorat T Lynch S Chin I Gonzalo A Rabano A Martinez S Daniel P Pramstaller H Morris N Wood A Lees C Tabernero T Nyggard AC Jackson A Hanson JG de Yebenes P Pramsteller 1999 Clinical genetics of familial progressive supranuclear palsy Brain 122 1233 1245
11. R Ros P Gomez Garre M Hirano YF Tai I Ampuero L Vidal A Rojo A Fontan A Vazquez S Fanjul J Hernandez S Cantarero J Hoenicka A Jones RL Ahsan N Pavese P Piccini DJ Brooks J Perez-Tur T Nyggard JG de Yebenes 2005 Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1 Ann Neurol 57 634 641
12. JC Steele JC Richardson J Olszewski 1964 Progressive Supranuclear Palsy Arch Neurol 10 333 359